Assessment | Time point | Purpose | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0Â weeks | 8Â weeks | 24Â weeks | Every therapy session | If early withdrawal | Describe sample | Determine eligibility | Feasibility of assessing efficacy | Feasibility of assessing change in mechanisms | Assess adverse events | MacCAT-T validation | |
MacCAT-T | X | X | X | Â | Â | X | X | X | Â | Â | X |
CIPD | X | Â | Â | Â | Â | X | X | Â | Â | Â | Â |
ISMI | X | Â | Â | Â | Â | X | X | Â | Â | Â | Â |
RSES | X | X | X | Â | Â | X | X | Â | X | Â | Â |
Beads Task | X | X | X | Â | Â | X | X | Â | X | Â | Â |
SIMS | X | X | X | Â | Â | X | Â | Â | X | Â | Â |
Demographics interviewa | X | Â | Â | Â | Â | X | Â | Â | Â | Â | Â |
BNA | X | Â | Â | Â | Â | X | Â | Â | Â | Â | Â |
PANSS | X | X | X | Â | Â | X | Â | X | Â | Â | Â |
QPR | X | X | X | Â | Â | X | Â | X | Â | Â | Â |
SQoL | X | X | X | Â | Â | X | Â | X | Â | Â | Â |
CSRI | X | X | X | Â | Â | X | Â | X | Â | Â | Â |
BAI | X | X | X | Â | Â | X | Â | X | Â | Â | Â |
BCSS | X | X | X | Â | Â | X | Â | X | Â | Â | Â |
CDSS | X | X | X | Â | Â | X | Â | X | Â | Â | Â |
CDSS item 8 (suicidality) | X | X | X | X | Â | X | Â | Â | Â | X | Â |
AEP—trial completers |  | X | X |  |  |  |  |  |  | X |  |
AEP—withdrawal |  |  |  |  | X |  |  |  |  | X |  |
CGI-P | X | X | X | X | Â | X | Â | Â | Â | X | Â |
CGI-R | X | X | X | X | Â | X | Â | Â | Â | X | Â |
SAI | X | X | X | Â | Â | X | Â | Â | Â | Â | X |
CGI-C | X | X | X | Â | Â | X | Â | Â | Â | Â | X |